ArticleHuman vaccines & immunotherapeutics2016

Post-marketing safety surveillance conducted in Korea (2008-2013) following the introduction of the rotavirus vaccine, RIX4414 (Rotarix™).

Son Moon Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.